Cargando…

克唑替尼联合脑转移灶切除、全脑放疗治疗ROS1阳性伴有症状脑转移的肺腺癌

BACKGROUND AND OBJECTIVE: Lung cancer with brain metastasis had poor prognosis.Crizotinib had been confirmed to be used in ROS1 (C-ros oncogene 1 receptor tyrosine kinase) rearranged lung adenocarcinoma, but its efficacy in lung cancer with brain metastasis was poor due to the blood brain barrier.In...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972988/
https://www.ncbi.nlm.nih.gov/pubmed/27561802
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.07